Reportedly, GCTG is highly expressed in a variety of cancers, including breast cancer, lung cancer, bladder cancer, colon cancer, osteosarcoma and glioma, suggesting that it may be the oncogene in these tumors (40–43). This evidence concerns the gene GGCT and urinary bladder cancer.